• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于新膀胱影像报告和数据系统(VI-RADS)的膀胱癌管理算法建议:从当前依赖经尿道膀胱肿瘤切除术(TURBT)的实践转变。

Proposal for a New Vesical Imaging-Reporting and Data System (VI-RADS)-Based Algorithm for the Management of Bladder Cancer: A Paradigm Shift From the Current Transurethral Resection of Bladder Tumor (TURBT)-Dependent Practice.

机构信息

Department of Urology, Kyorin University School of Medicine, Tokyo, Japan.

Department of Radiology, Kyorin University School of Medicine, Tokyo, Japan.

出版信息

Clin Genitourin Cancer. 2022 Aug;20(4):e291-e295. doi: 10.1016/j.clgc.2022.03.002. Epub 2022 Mar 4.

DOI:10.1016/j.clgc.2022.03.002
PMID:35346591
Abstract

Transurethral resection of bladder tumor (TURBT) is the essential first step in the current algorithm for the management of bladder cancer (BC). However, despite its necessity and significance, TURBT has several limitations, including cost, hospitalization, anesthesia, potential complications such as bladder perforation, and delay to radical cystectomy. The Vesical Imaging Reporting and Data System (VI-RADS) was developed to standardize the reporting of multiparametric magnetic resonance imaging for BC, and its diagnostic accuracy to predict muscle invasion has been validated. Given the high sensitivity of VI-RADS ≥ 3 and high specificity of VI-RADS ≥ 4 as clinically relevant cutoff values, we herein propose a new VI-RADS-based algorithm for the management of BC. Using this algorithm, patients with VI-RADS ≤ 2 may not need to undergo sampling of the detrusor muscle nor second TURBT even if there is no muscle in the initial TURBT specimen, whereas patients with VI-RADS ≥ 4 may skip conventional TURBT aimed at pathologic confirmation of muscle invasion and immediately undergo radical cystectomy. Our newly proposed algorithm enables the avoidance of unnecessary deep resection or second TURBT as well as delay to radical cystectomy. The VI-RADS-based algorithm enables a paradigm shift from the current TURBT-dependent practice in the management of BC.

摘要

经尿道膀胱肿瘤切除术(TURBT)是当前膀胱癌(BC)管理算法的重要第一步。然而,尽管 TURBT 具有必要性和重要性,但它存在一些局限性,包括成本、住院时间、麻醉、膀胱穿孔等潜在并发症以及对根治性膀胱切除术的延迟。Vesical Imaging Reporting and Data System(VI-RADS)的开发是为了标准化 BC 的多参数磁共振成像报告,其诊断准确性已被验证可预测肌肉侵犯。鉴于 VI-RADS≥3 的高敏感性和 VI-RADS≥4 的高特异性作为临床相关的截止值,我们在此提出了一种基于 VI-RADS 的新 BC 管理算法。使用该算法,VI-RADS≤2 的患者即使初始 TURBT 标本中没有肌肉,也可能不需要对逼尿肌进行取样,也不需要进行第二次 TURBT,而 VI-RADS≥4 的患者可能可以跳过旨在病理确认肌肉侵犯的常规 TURBT,直接进行根治性膀胱切除术。我们新提出的算法可以避免不必要的深度切除或第二次 TURBT 以及对根治性膀胱切除术的延迟。基于 VI-RADS 的算法使 BC 管理从当前依赖 TURBT 的实践范式发生转变。

相似文献

1
Proposal for a New Vesical Imaging-Reporting and Data System (VI-RADS)-Based Algorithm for the Management of Bladder Cancer: A Paradigm Shift From the Current Transurethral Resection of Bladder Tumor (TURBT)-Dependent Practice.基于新膀胱影像报告和数据系统(VI-RADS)的膀胱癌管理算法建议:从当前依赖经尿道膀胱肿瘤切除术(TURBT)的实践转变。
Clin Genitourin Cancer. 2022 Aug;20(4):e291-e295. doi: 10.1016/j.clgc.2022.03.002. Epub 2022 Mar 4.
2
Preoperative detection of Vesical Imaging-Reporting and Data System (VI-RADS) score 5 reliably identifies extravesical extension of urothelial carcinoma of the urinary bladder and predicts significant delayed time to cystectomy: time to reconsider the need for primary deep transurethral resection of bladder tumour in cases of locally advanced disease?术前膀胱成像报告和数据系统(VI-RADS)评分 5 可可靠识别膀胱癌的膀胱外延伸,并预测显著的膀胱切除术延迟时间:是否需要重新考虑局部进展性疾病患者行原发性经尿道膀胱肿瘤深度切除术?
BJU Int. 2020 Nov;126(5):610-619. doi: 10.1111/bju.15188. Epub 2020 Aug 17.
3
Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection.前瞻性评估膀胱影像报告和数据系统(VI-RADS)及其对高危非肌肉浸润性膀胱癌患者重复经尿道切除术候选者管理的临床影响。
Eur Urol. 2020 Jan;77(1):101-109. doi: 10.1016/j.eururo.2019.09.029. Epub 2019 Nov 5.
4
Clinical utility of vesical imaging-reporting and data system (VI-RADS) in non-muscle invasive bladder cancer (NMIBC) patients candidate for en-bloc transurethral resection: A prospective study.膀胱影像报告和数据系统(VI-RADS)在整块经尿道切除候选非肌肉浸润性膀胱癌(NMIBC)患者中的临床应用:一项前瞻性研究。
Urol Oncol. 2022 Oct;40(10):454.e1-454.e7. doi: 10.1016/j.urolonc.2022.03.008. Epub 2022 Apr 22.
5
Performance of VI-RADS in predicting muscle-invasive bladder cancer after transurethral resection: a single center retrospective analysis.VI-RADS 在经尿道膀胱肿瘤切除术后预测肌层浸润性膀胱癌中的表现:单中心回顾性分析。
Abdom Radiol (NY). 2024 May;49(5):1593-1602. doi: 10.1007/s00261-024-04245-4. Epub 2024 Mar 19.
6
Is high accuracy of Vesical Imaging-Reporting and Data System (VI-RADS) sufficient for its implementation in the urological practice?膀胱影像报告和数据系统(VI-RADS)的高精度是否足以使其在泌尿外科实践中得到实施?
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2023 Mar;167(1):85-90. doi: 10.5507/bp.2022.054. Epub 2023 Jan 2.
7
The validity, reliability, and reviewer acceptance of VI-RADS in assessing muscle invasion by bladder cancer: a multicenter prospective study.VI-RADS 在评估膀胱癌肌层侵犯中的有效性、可靠性和评审者接受度:一项多中心前瞻性研究。
Eur Radiol. 2021 Sep;31(9):6949-6961. doi: 10.1007/s00330-021-07765-5. Epub 2021 Feb 19.
8
VI-RADS: Multiinstitutional Multireader Diagnostic Accuracy and Interobserver Agreement Study.VI-RADS:多机构多阅片者诊断准确性及观察者间一致性研究
AJR Am J Roentgenol. 2021 May;216(5):1257-1266. doi: 10.2214/AJR.20.23604. Epub 2020 Jul 29.
9
Multiparametric MRI of the bladder: inter-observer agreement and accuracy with the Vesical Imaging-Reporting and Data System (VI-RADS) at a single reference center.膀胱多参数 MRI:在单一参考中心使用 Vesical Imaging-Reporting and Data System(VI-RADS)的观察者间一致性和准确性。
Eur Radiol. 2019 Oct;29(10):5498-5506. doi: 10.1007/s00330-019-06117-8. Epub 2019 Mar 18.
10
Comparison of staging MRI to re-resection for localised bladder cancer: Narrative review.局部膀胱癌分期MRI与再次切除的比较:叙述性综述。
BJUI Compass. 2024 Apr 24;5(7):651-661. doi: 10.1002/bco2.365. eCollection 2024 Jul.

引用本文的文献

1
Utility of MRI in NMIBC and feasibility of avoiding Re-TURB in carefully selected patients: a systematic review.MRI在非肌层浸润性膀胱癌中的应用及在精心挑选的患者中避免再次经尿道膀胱肿瘤电切术的可行性:一项系统评价
World J Urol. 2025 Jan 30;43(1):95. doi: 10.1007/s00345-025-05473-z.
2
Transurethral resection of bladder tumor with Bacille Calmette-Guerin intravesical instillation for HRNMIBC and factors influencing recurrence.经尿道膀胱肿瘤切除术联合卡介苗膀胱灌注治疗高危非肌层浸润性膀胱癌及复发影响因素
Am J Transl Res. 2024 Nov 15;16(11):6914-6924. doi: 10.62347/UVFF9164. eCollection 2024.
3
ASO Author Reflections: Reevaluating Muscle Invasion in Bladder Cancer: The Role of VI-RADS in Guiding Re-resections/ Re-stage TURBT.
ASO作者反思:重新评估膀胱癌中的肌肉浸润:VI-RADS在指导再次切除/重新分期经尿道膀胱肿瘤电切术中的作用。
Ann Surg Oncol. 2025 Jan;32(1):621-622. doi: 10.1245/s10434-024-16475-3. Epub 2024 Nov 11.
4
The Role of Maximal TURBT in Muscle-Invasive Bladder Cancer: Balancing Benefits in Bladder Preservation and Beyond.最大程度经尿道膀胱肿瘤切除术在肌层浸润性膀胱癌中的作用:平衡膀胱保留及其他方面的获益
Cancers (Basel). 2024 Sep 30;16(19):3361. doi: 10.3390/cancers16193361.
5
Comparison of staging MRI to re-resection for localised bladder cancer: Narrative review.局部膀胱癌分期MRI与再次切除的比较:叙述性综述。
BJUI Compass. 2024 Apr 24;5(7):651-661. doi: 10.1002/bco2.365. eCollection 2024 Jul.
6
MRI evaluation of vesical imaging reporting and data system for bladder cancer after neoadjuvant chemotherapy.MRI 评估膀胱癌新辅助化疗后膀胱成像报告和数据系统。
Cancer Imaging. 2024 Apr 8;24(1):49. doi: 10.1186/s40644-024-00696-6.
7
Accuracy of actual stage prediction using Vesical Imaging Reporting and Data System (VI-RADS) before radical cystectomy for urothelial carcinoma in SUPER-UC-Cx.在SUPER-UC-Cx中,根治性膀胱切除术前行膀胱影像报告和数据系统(VI-RADS)对尿路上皮癌实际分期预测的准确性。
Transl Androl Urol. 2023 Feb 28;12(2):168-175. doi: 10.21037/tau-22-704. Epub 2023 Feb 3.